The Implementation Timeline of the One Big Beautiful Bill Act - Center for American Progress
4 days ago • Google News
Impel Neuropharma Inc (IMPL)
US$ 0.84450%
Price Chart
Key Statistics
Market Cap
$ 5.76M
P/E Ratio
0.00
Revenue (TTM)
$ 20.99M
Volume
5.97M
52W High
$ 0.00
52W Low
$ 0.00
Dividend Yield
0.00%
Beta
1.17
Technicals
50-Day MA
0.3116
200-Day MA
0.9332
52 Week High
N/A
52 Week Low
N/A
About IMPL
Impel Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapies for patients suffering from central nervous system disease in th.
Employees
160
Headquarters
Seattle, WA
CEO
Mr. Adrian Adams
Latest News
New lawsuit scrutinizes Hegseth’s implementation of Trump’s anti-union EO - Government Executive
3 days ago • Google News
Game changer: How AI simplifies implementation of Zero Trust security objectives - csoonline.com
3 days ago • Google News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg